Lava Therapeutics Nv (LVTX)

Sep 30, 2024

Lava Therapeutics' SWOT analysis: oncology biotech's stock potential amid trials - Investing.com UK

Sep 30, 2024

Sep 21, 2024

Xinhua News | Portuguese scientists discover new approach to combat Alzheimer's disease - Xinhua

Sep 21, 2024

Sep 16, 2024

After the Lykos debacle, what’s next for psychedelic therapies? - Pharmaceutical Technology

Sep 16, 2024

Sep 16, 2024

Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024 - BioSpace

Sep 16, 2024

Sep 05, 2024

LAVA Therapeutics Announces Appointment of Amy Garabedian as General Counsel and Corporate Secretary - Yahoo Finance UK

Sep 05, 2024

Sep 04, 2024

LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance UK

Sep 04, 2024

Sep 04, 2024

LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference - Yahoo Finance UK

Sep 04, 2024

Sep 03, 2024

LVTXLAVA Therapeutics N.V. Ordinary Shares Latest Stock News & Market Updates - StockTitan

Sep 03, 2024

Aug 22, 2024

LAVA Therapeutics (NASDAQ:LVTX) Given Market Outperform Rating at JMP Securities - Defense World

Aug 22, 2024

Aug 21, 2024

LAVA Therapeutics (NASDAQ:LVTX) Issues Earnings Results - Defense World

Aug 21, 2024

Aug 20, 2024

LAVA Therapeutics Faces Financial Hurdles - TipRanks

Aug 20, 2024

Aug 20, 2024

LAVA Reports Second Quarter 2024 Financial Results and Business Update - GlobeNewswire

Aug 20, 2024

Aug 16, 2024

LAVA Therapeutics NV expected to post a loss of 36 cents a shareEarnings Preview - XM

Aug 16, 2024

Aug 13, 2024

LAVA Therapeutics (NASDAQ:LVTX) Stock Price Up 2.3% - Defense World

Aug 13, 2024

Jul 22, 2024

All You Need to Know About LAVA Therapeutics (LVTX) Rating Upgrade to Strong Buy - Yahoo Finance Australia

Jul 22, 2024

Jul 21, 2024

LAVA Therapeutics (NASDAQ:LVTX) Shares Down 0.7% - American Banking and Market News

Jul 21, 2024

Jul 20, 2024

LAVA Therapeutics (NASDAQ:LVTX) Trading Down 0.7% - Defense World

Jul 20, 2024

Jul 03, 2024

Investors in LAVA Therapeutics (NASDAQ:LVTX) from a year ago are still down 16%, even after 44% gain this past week - Yahoo Lifestyle Australia

Jul 03, 2024

Jun 29, 2024

LAVA Therapeutics (NASDAQ:LVTX) Receives Buy Rating from HC Wainwright - Defense World

Jun 29, 2024

Jun 28, 2024

Cathie Wood's ARK ETF focuses on PagerDuty, 10X Genomics stock By Investing.com - Investing.com

Jun 28, 2024

Jun 28, 2024

Lava Therapeutics shares hold target with Buy rating By Investing.com - Investing.com India

Jun 28, 2024

Jun 28, 2024

Macquarie starts Ensign Group stock coverage with outperform rating By Investing.com - Investing.com India

Jun 28, 2024

Jun 28, 2024

Barclays sets Charles River Labs stock target with Equalweight rating By Investing.com - Investing.com India

Jun 28, 2024

Jun 28, 2024

Citi reaffirms sell on Dr. Reddy's shares amid acquisition deal By Investing.com - Investing.com

Jun 28, 2024

Jun 28, 2024

Jefferies sets buy rating on Syndax stock By Investing.com - Investing.com UK

Jun 28, 2024

Jun 28, 2024

UBS starts Hydro One stock coverage with neutral rating By Investing.com - Investing.com UK

Jun 28, 2024

Jun 28, 2024

Lava Therapeutics shares hold target with Buy rating - Investing.com India

Jun 28, 2024

Jun 27, 2024

JPMorgan starts PagerDuty stock with neutral rating amid 'competitive landscape' By Investing.com - Investing.com Australia

Jun 27, 2024

Jun 27, 2024

Cava group director Bosserman sells over $2.7 million in company stock By Investing.com - Investing.com Canada

Jun 27, 2024

Jun 25, 2024

Goldman Sachs sets target on Paramount shares, initiates with sell By Investing.com - Investing.com

Jun 25, 2024

Jun 21, 2024

Transocean adjusts share capital and treasury shares By Investing.com - Investing.com

Jun 21, 2024

Jun 20, 2024

LAVA Therapeutics Shareholders Approve Key ResolutionsTipRanks.com - TipRanks

Jun 20, 2024

Jun 19, 2024

Metric Analysis: LAVA Therapeutics NV (LVTX)'s Key Ratios in the Limelight – DWinneX - The Dwinnex

Jun 19, 2024

Jun 17, 2024

Kayne Anderson BDC stock gets Market Perform from KBW, notes stable industry focus By Investing.com - Investing.com

Jun 17, 2024

Jun 14, 2024

Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace

Jun 14, 2024

Jun 14, 2024

Kinsale Capital's president and COO sells shares worth over $579,000 By Investing.com - Investing.com South Africa

Jun 14, 2024

Jun 10, 2024

LAVA Announces Annual Meeting of Shareholders - GlobeNewswire

Jun 10, 2024

Jun 07, 2024

BioCardia secures patent for cardiac delivery catheter By Investing.com - Investing.com India

Jun 07, 2024

Jun 06, 2024

Karyopharm CEO sells shares worth $3,556 By Investing.com - Investing.com

Jun 06, 2024